Cargando…
Breast Cancer Heterogeneity and Response to Novel Therapeutics
SIMPLE SUMMARY: Breast cancer is a heterogeneous disease that is driven by genetic, epigenetic and phenotypic modifications and is also affected by the microenvironment and the metabolism. In this article we review genetic and non-genetic causes of tumor heterogeneity focusing on the impact that het...
Autores principales: | Baliu-Piqué, Mariona, Pandiella, Atanasio, Ocana, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694303/ https://www.ncbi.nlm.nih.gov/pubmed/33167363 http://dx.doi.org/10.3390/cancers12113271 |
Ejemplares similares
-
Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2020) -
BET inhibitors as novel therapeutic agents in breast cancer
por: Ocaña, Alberto, et al.
Publicado: (2017) -
Genomic Mapping Identifies Mutations in RYR2 and AHNAK as Associated with Favorable Outcome in Basal-Like Breast Tumors Expressing PD1/PD-L1
por: Cimas, Francisco J., et al.
Publicado: (2020) -
Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation
por: Noblejas-López, María del Mar, et al.
Publicado: (2021) -
Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies
por: Ocana, Alberto, et al.
Publicado: (2017)